Talk:Yohimbine
Jump to navigation
Jump to search
| This is the talk page for discussing improvements to the Yohimbine article. This is not a forum for general discussion of the article's subject. |
Article policies
|
| Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
Archives: Index, 1Auto-archiving period: 90 days  |
 | This article is rated C-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||
| |||||||||||||||||||||
 | Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Yohimbine.
|
.svg){kind=small} | Daily pageviews of this article
A graph should have been displayed here but graphs are temporarily disabled. Until they are enabled again, visit the interactive graph at pageviews.wmcloud.org |
 Archives (Index) |
|
This page is archived by ClueBot III.
|
Research
In this section, there is a "See also" for Anabolic-androgenic steroids abuse#Childhood trauma. Looking through that target page's history, it was changed to a redirect to Anabolic steroid in this edit. The old content of that article mentions common occurrence of CSA/trauma in (ab)users of anabolic steroids. The Research section here mentions it being potentially useful for PTSD.
Given that the "See also" target has been changed to a redirect, and Anabolic steroid does not mention this co-occurrence, I am removing this "See also" tag. Kimen8 (talk) 23:32, 15 October 2023 (UTC)